Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer
- 31 January 1986
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 24 (1) , 139-146
- https://doi.org/10.1016/0022-4731(86)90043-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Continuous subcutaneous administration of ‘Zoladex’ (ICI 118,630 — an LH-RH analogue) to patients with advanced prostatic cancerJournal of Steroid Biochemistry, 1984
- Ketoconazole: A Novel and Rapid Treatment for Advanced Prostatic CancerJournal of Urology, 1983
- LH‐RH Agonists and AntagonistsInternational Journal of Gynecology & Obstetrics, 1980
- Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing HormoneFertility and Sterility, 1978
- POTENT INHIBITORY ACTIVITY OF [D-LEU6, DES-GLY-NH21Q]LHRH ETHYLAMIDE ON LH/hCG AND PRL TESTICULAR RECEPTOR LEVELS IN THE RATEndocrinology, 1977
- Selective Effect of Androgens on LH and FSH Release in Anterior Pituitary Cells in CultureEndocrinology, 1976
- Aminoglutethimide Medical Adrenalectomy for Advanced Prostatic CarcinomaJournal of Urology, 1976
- Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the ProstateJournal of Urology, 1975
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973